Leistritz to Host Pharmaceutical-Nutraceutical Extrusion Seminar

News
Article

The “hands-on” seminar will be held June 12–13, 2019 and will feature educational sessions and demonstrations in the company’s process laboratory.

Leistritz will be hosting its annual Pharmaceutical-Nutraceutical Extrusion Seminar from June 12–13, 2019 in Clinton, NJ. The seminar will feature sessions on twin-screw extrusion theory and design and “hands-on” demonstrations at the company’s process laboratory. 

Specific session topics will include the following:

  • Twin screw extrusion theory and design

  • Downstream systems: pelletizing, tubes, filaments, films, and unique shape extrusion

  • Die design, rheological characterization, and computer modeling

  • Single screw extrusion theory and design

  • Upstream equipment designs for feeding, material handling, and containment

  • Scale-up of the extrusion process: R&D, pilot scale, and production

  • Cleaning and maintenance of extrusion equipment in a cGMP environment

  • Equipment and process validation practices and documentation

  • Foaming and co-extrusion.

 Demonstrations include:

  • Nano-16 twin screw extrusion system processing 50-gram batch samples

  • Film/lamination extrusion system for transdermal and dissolvable film applications

  • Foaming of an extrudate via carbon dioxide injection

  • Hot-face die cutting of nutritional products

  • 3D filament and tube extrusion

  • Screw assembly/disassembly procedures.

Classroom sessions will be held at the Holiday Inn Select in Clinton, NJ, and extrusion demonstrations will be held at the Leistritz Process Laboratory. For more information contact May Zaw at 908.685.2333 x614 or e-mail mzaw@leistritz-extrusion.com.

Source: Leistritz

 

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content